Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Industrifonden in connection with the investment round in Amra
Mandate

Vinge advises Industrifonden in connection with the investment round in Amra

January 24, 2017

Vinge has advised Industrifonden in connection with an investment round of USD 9 million for the digital health company Advanced MR Analytics AB (AMRA).

The investment round was led by Pfizer Venture Investments and VC Novo Seeds together with the existing investor Industrifonden.

AMRA has developed a method for measuring body fat and muscle mass using a magnetic camera. The company’s aim is to assess the risk of serious illness based upon the patient’s body profile. The investment round facilitates an international establishment and an expanded network among leading pharmaceutical companies.

Vinge’s team consisted of Johan Larsson and Johan Mattsson.

Related

Vinge advises SAGA Diagnostics AB on convertible note issue

 SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

 Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023

Vinge has advised private equity firm Stirling Square Capital Partners

 Vinge has advised private equity firm Stirling Square Capital Partners in connection with its acquisition of a majority stake in Infobric, a leading provider of software solutions for the construction industry, from Summa Equity.
September 22, 2023